OrbiMed’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,382,502
| Closed | -$12.6M | – | 123 |
|
|
2019
Q2 | $12.6M | Sell |
1,382,502
-599,529
| -30% | -$5.46M | 0.19% | 81 |
|
|
2019
Q1 | $27.5M | Buy |
1,982,031
+544,300
| +38% | +$7.55M | 0.43% | 60 |
|
|
2018
Q4 | $22.7M | Sell |
1,437,731
-600,144
| -29% | -$9.47M | 0.42% | 63 |
|
|
2018
Q3 | $39.4M | Buy |
2,037,875
+734,920
| +56% | +$14.2M | 0.48% | 62 |
|
|
2018
Q2 | $9.51M | Hold |
1,302,955
| – | – | 0.11% | 110 |
|
|
2018
Q1 | $4.01M | Hold |
1,302,955
| – | – | 0.05% | 117 |
|
|
2017
Q4 | $4.2M | Sell |
1,302,955
-992,391
| -43% | -$3.2M | 0.05% | 116 |
|
|
2017
Q3 | $11.1M | Sell |
2,295,346
-10,100
| -0.4% | -$49K | 0.11% | 103 |
|
|
2017
Q2 | $12M | Hold |
2,305,446
| – | – | 0.13% | 95 |
|
|
2017
Q1 | $11.5M | Hold |
2,305,446
| – | – | 0.13% | 90 |
|
|
2016
Q4 | $11.3M | Hold |
2,305,446
| – | – | 0.14% | 85 |
|
|
2016
Q3 | $15.4M | Hold |
2,305,446
| – | – | 0.18% | 83 |
|
|
2016
Q2 | $11.2M | Hold |
2,305,446
| – | – | 0.12% | 87 |
|
|
2016
Q1 | $11.3M | Buy |
2,305,446
+33,946
| +1% | +$166K | 0.12% | 86 |
|
|
2015
Q4 | $19.7M | Buy |
2,271,500
+430,100
| +23% | +$3.73M | 0.18% | 70 |
|
|
2015
Q3 | $26.8M | Buy |
1,841,400
+10,000
| +0.5% | +$146K | 0.27% | 65 |
|
|
2015
Q2 | $30.5M | Hold |
1,831,400
| – | – | 0.26% | 68 |
|
|
2015
Q1 | $40.1M | Buy |
1,831,400
+2,000
| +0.1% | +$43.8K | 0.34% | 56 |
|
|
2014
Q4 | $39.6M | Buy |
1,829,400
+879,400
| +93% | +$19.1M | 0.38% | 55 |
|
|
2014
Q3 | $16.3M | Buy |
+950,000
| New | +$16.3M | 0.17% | 77 |
|